Global Inherited Retinal Disease Market Report 2025

Inherited Retinal Disease Global Market Report 2025 – By Type (Diagnosis, Therapy), By Disease Type (Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases), By Distribution Channel (Retail Sales, Direct Tender), By End Users (Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End UsersSubsegments, – By Diagnosis (Genetic Testing (Genetic Screening), Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)), Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging), By Therapy (Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy (Gene Editing, Retinal Drugs), Photoreceptor Rescue Therapy) – Market Size, Trends, And Global Forecast 2025-2034

Inherited Retinal Disease Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Inherited Retinal Disease Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Inherited Retinal Disease Market Definition

Inherited retinal diseases are a group of rare, genetic eye disorders caused by mutations in specific genes. These diseases primarily affect the retina, the thin layer of light-sensitive tissue at the back of the eye. They often present challenges for treatment due to their genetic complexity, but advancements in gene therapy and other innovative technologies offer promising solutions.

The main types of treatment for inherited retinal disease are diagnosis, and therapy. Diagnosis involves the use of advanced technologies such as genetic testing, optical coherence tomography, and fundus imaging to identify inherited retinal diseases and their underlying genetic causes. These are used to treat various diseases such as retinitis pigmentosa, choroideremia, stargardt disease, cone-rode dystrophy, leber congenital amaurosis, and others and are distributed through various distribution channels such as retail sales, and direct tender, and used by various end users such as hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others.

Inherited Retinal Disease Market Segmentation

The inherited retinal disease market covered in this report is segmented –

1) By Type: Diagnosis, Therapy

2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases

3) By Distribution Channel: Retail Sales, Direct Tender

4) By End Users: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users

Subsegments,

1) By Diagnosis: Genetic Testing (Genetic Screening), Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)), Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging

2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy (Gene Editing, Retinal Drugs), Photoreceptor Rescue Therapy

Inherited Retinal Disease Market Size and growth rate 2025 to 2029: Graph

Inherited Retinal Disease Market Size 2025 And Growth Rate

The inherited retinal disease market size has grown strongly in recent years. It will grow from $11.56 billion in 2024 to $12.58 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to the adoption of gene therapy, regulatory incentives, growth in patient registries, rise in clinical trials, and rise in patient-centric solutions.

Inherited Retinal Disease Market Growth Forecast

The inherited retinal disease market size is expected to see strong growth in the next few years. It will grow to $17.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the increasing use of CRISPR, the emergence of personalized treatment, the focus on regenerative medicine, the growth in patient advocacy, and the focus on improving the quality of life for patients. Major trends in the forecast period include advancements in optogenetics technology, development of artificial retina implants, expansion of digital health platforms, integration of artificial intelligence in disease modeling, and use of artificial intelligence in planning treatment.

Inherited Retinal Disease Market Driver: Rising Macular Degeneration Cases Boost Market Growth

The increasing prevalence of macular degeneration is expected to propel the growth of the inherited retinal disease market going forward. Macular degeneration is an age-related eye condition that damages the macula, leading to central vision loss and difficulty in activities such as reading or recognizing faces. The increasing prevalence of macular degeneration is driven by aging populations, higher life expectancy, and lifestyle factors such as smoking and poor nutrition, which elevate risk. Inherited retinal disease treatment helps macular degeneration patients by targeting the underlying genetic causes of retinal degeneration, providing therapies that slow disease progression, restore lost vision, or even prevent further damage to the retina, ultimately improving visual outcomes and quality of life for individuals affected by age-related or inherited forms of macular degeneration. For instance, in February 2024, according to the Canadian Ophthalmological Society, a Canada-based nonprofit organization, reported that 2.5 million people in Canada aged over 55 lose their vision due to age-related macular degeneration (AMD). Therefore, the increasing prevalence of macular degeneration is driving the growth of the inherited retinal disease market.

Global Inherited Retinal Disease Market Major Players

Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

Global Inherited Retinal Disease Market Trend: Innovation In Mutation-Agnostic Gene Therapy Shaping The Market

Major companies operating in the inherited retinal diseases market focus on developing innovative therapies, such as mutation-agnostic gene therapy, to provide inclusive treatment options and address a wider range of genetic variations associated with these conditions. Mutation-agnostic gene therapy is a treatment approach targeting broader genetic mechanisms or pathways, rather than specific mutations, making it applicable to diverse genetic disorders. For instance, in March 2024, Nanoscope Therapeutics Inc, a US-based biotechnology company, announced positive results of a clinical trial of its lead program, MCO-010, which demonstrates vision improvements for patients with permanent and severe vision loss from advanced retinitis pigmentosa. MCO-010 achieved its primary and key secondary endpoints with statistical significance and no serious adverse events.

Inherited Retinal Disease Market Merger And Acquisition: Ocuphire Pharma Acquires Opus Genetics For Gene Therapy Development

In October 2024, Ocuphire Pharma, Inc. a US based biopharmaceutical company acquired Opus Genetics Inc. for an undisclosed amount. With this acquisition, Ocuphire Pharma, Inc. aims to strengthen its gene therapy portfolio and accelerate the development of innovative treatments for inherited retinal diseases (IRDs) by integrating Opus Genetics Inc.'s cutting-edge gene therapies targeting rare retinal conditions. Opus Genetics Inc. is a US based clinical stage gene therapy company focused on inherited retinal diseases.

Regional Outlook For The Global Inherited Retinal Disease Market

North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the inherited retinal disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Inherited Retinal Disease Market?

The inherited retinal disease market includes revenues earned by entities by providing services such as ophthalmic tests, optic nerve imaging, and electrophysiological tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Inherited Retinal Disease Industry?

The inherited retinal disease market research report is one of a series of new reports from The Business Research Company that provides inherited retinal disease market statistics, including inherited retinal disease industry global market size, regional shares, competitors with a inherited retinal disease market share, detailed inherited retinal disease market segments, market trends and opportunities, and any further data you may need to thrive in the inherited retinal disease industry. This inherited retinal disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Inherited Retinal Disease Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 12.58 billion
Revenue Forecast In 2034 $17.42 billion
Growth Rate CAGR of 8.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The inherited retinal disease market covered in this report is segmented –
1) By Type: Diagnosis, Therapy
2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases
3) By Distribution Channel: Retail Sales, Direct Tender
4) By End Users: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users Subsegments,
1) By Diagnosis: Genetic Testing (Genetic Screening), Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)), Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging
2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy (Gene Editing, Retinal Drugs), Photoreceptor Rescue Therapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Inherited Retinal Disease Market Characteristics

    3. Inherited Retinal Disease Market Trends And Strategies

    4. Inherited Retinal Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Inherited Retinal Disease Growth Analysis And Strategic Analysis Framework

    5.1. Global Inherited Retinal Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Inherited Retinal Disease Market Growth Rate Analysis

    5.4. Global Inherited Retinal Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Inherited Retinal Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Inherited Retinal Disease Total Addressable Market (TAM)

    6. Inherited Retinal Disease Market Segmentation

    6.1. Global Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Diagnosis

    Therapy

    6.2. Global Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Retinitis Pigmentosa

    Choroideremia

    Stargardt Disease

    Cone-rode Dystrophy

    Leber Congenital Amaurosis

    Other Diseases

    6.3. Global Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Retail Sales

    Direct Tender

    6.4. Global Inherited Retinal Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Speciality Clinics

    Ambulatory Surgical Centres

    Home Healthcare

    Other End Users

    6.5. Global Inherited Retinal Disease Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Genetic Testing (Genetic Screening)

    Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT))

    Electrophysiological Testing (Electroretinography)

    Visual Field Testing

    Fundus Autofluorescence Imaging

    6.6. Global Inherited Retinal Disease Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Gene Therapy

    Stem Cell Therapy

    Retinal Prosthesis (Artificial Retina)

    Pharmacological Therapy (Gene Editing, Retinal Drugs)

    Photoreceptor Rescue Therapy

    7. Inherited Retinal Disease Market Regional And Country Analysis

    7.1. Global Inherited Retinal Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Inherited Retinal Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Inherited Retinal Disease Market

    8.1. Asia-Pacific Inherited Retinal Disease Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Inherited Retinal Disease Market

    9.1. China Inherited Retinal Disease Market Overview

    9.2. China Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Inherited Retinal Disease Market

    10.1. India Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Inherited Retinal Disease Market

    11.1. Japan Inherited Retinal Disease Market Overview

    11.2. Japan Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Inherited Retinal Disease Market

    12.1. Australia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Inherited Retinal Disease Market

    13.1. Indonesia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Inherited Retinal Disease Market

    14.1. South Korea Inherited Retinal Disease Market Overview

    14.2. South Korea Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Inherited Retinal Disease Market

    15.1. Western Europe Inherited Retinal Disease Market Overview

    15.2. Western Europe Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Inherited Retinal Disease Market

    16.1. UK Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Inherited Retinal Disease Market

    17.1. Germany Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Inherited Retinal Disease Market

    18.1. France Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Inherited Retinal Disease Market

    19.1. Italy Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Inherited Retinal Disease Market

    20.1. Spain Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Inherited Retinal Disease Market

    21.1. Eastern Europe Inherited Retinal Disease Market Overview

    21.2. Eastern Europe Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Inherited Retinal Disease Market

    22.1. Russia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Inherited Retinal Disease Market

    23.1. North America Inherited Retinal Disease Market Overview

    23.2. North America Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Inherited Retinal Disease Market

    24.1. USA Inherited Retinal Disease Market Overview

    24.2. USA Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Inherited Retinal Disease Market

    25.1. Canada Inherited Retinal Disease Market Overview

    25.2. Canada Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Inherited Retinal Disease Market

    26.1. South America Inherited Retinal Disease Market Overview

    26.2. South America Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Inherited Retinal Disease Market

    27.1. Brazil Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Inherited Retinal Disease Market

    28.1. Middle East Inherited Retinal Disease Market Overview

    28.2. Middle East Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Inherited Retinal Disease Market

    29.1. Africa Inherited Retinal Disease Market Overview

    29.2. Africa Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Inherited Retinal Disease Market Competitive Landscape And Company Profiles

    30.1. Inherited Retinal Disease Market Competitive Landscape

    30.2. Inherited Retinal Disease Market Company Profiles

    30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Vertex Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Inherited Retinal Disease Market Other Major And Innovative Companies

    31.1. Ionis Pharmaceuticals Inc.

    31.2. Invitae Corporation

    31.3. Spark Therapeutics

    31.4. Aldeyra Therapeutics

    31.5. Regenxbio Inc.

    31.6. IVERIC bio

    31.7. MeiraGTx Limited

    31.8. Ocugen Inc.

    31.9. Coave Therapeutics

    31.10. Bionic Vision Technologies

    31.11. GenSight Biologics SA

    31.12. LKC Technologies Inc.

    31.13. Sparing Vision

    31.14. ProQR Therapeutics NV

    31.15. Endogena Therapeutics

    32. Global Inherited Retinal Disease Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Inherited Retinal Disease Market

    34. Recent Developments In The Inherited Retinal Disease Market

    35. Inherited Retinal Disease Market High Potential Countries, Segments and Strategies

    35.1 Inherited Retinal Disease Market In 2029 - Countries Offering Most New Opportunities

    35.2 Inherited Retinal Disease Market In 2029 - Segments Offering Most New Opportunities

    35.3 Inherited Retinal Disease Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Inherited Retinal Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Inherited Retinal Disease Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Inherited Retinal Disease Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Inherited Retinal Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Inherited Retinal Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Johnson & Johnson Financial Performance
  • Table 78: Novartis AG Financial Performance
  • Table 79: Astellas Pharma Inc. Financial Performance
  • Table 80: Biogen Inc. Financial Performance
  • Table 81: Vertex Pharmaceuticals Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Inherited Retinal Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Inherited Retinal Disease Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Inherited Retinal Disease Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Inherited Retinal Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Inherited Retinal Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Johnson & Johnson Financial Performance
  • Figure 78: Novartis AG Financial Performance
  • Figure 79: Astellas Pharma Inc. Financial Performance
  • Figure 80: Biogen Inc. Financial Performance
  • Figure 81: Vertex Pharmaceuticals Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Inherited Retinal Disease market?

Inherited retinal diseases are a group of rare, genetic eye disorders caused by mutations in specific genes. These diseases primarily affect the retina, the thin layer of light-sensitive tissue at the back of the eye. They often present challenges for treatment due to their genetic complexity, but advancements in gene therapy and other innovative technologies offer promising solutions. For further insights on the Inherited Retinal Disease market, request a sample here

How will the Inherited Retinal Disease market drivers and restraints affect the market dynamics? What forces will shape the Inherited Retinal Disease industry going forward?

The Inherited Retinal Disease market major growth driver - Rising Macular Degeneration Cases Boost Market Growth. For further insights on the Inherited Retinal Disease market, request a sample here

What is the forecast market size or the forecast market value of the Inherited Retinal Disease market?

The Inherited Retinal Disease market size has grown strongly in recent years. The inherited retinal disease market size has grown strongly in recent years. It will grow from $11.56 billion in 2024 to $12.58 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to the adoption of gene therapy, regulatory incentives, growth in patient registries, rise in clinical trials, and rise in patient-centric solutions. The inherited retinal disease market size is expected to see strong growth in the next few years. It will grow to $17.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the increasing use of CRISPR, the emergence of personalized treatment, the focus on regenerative medicine, the growth in patient advocacy, and the focus on improving the quality of life for patients. Major trends in the forecast period include advancements in optogenetics technology, development of artificial retina implants, expansion of digital health platforms, integration of artificial intelligence in disease modeling, and use of artificial intelligence in planning treatment. For further insights on the Inherited Retinal Disease market, request a sample here

How is the Inherited Retinal Disease market segmented?

The inherited retinal disease market covered in this report is segmented –
1) By Type: Diagnosis, Therapy
2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases
3) By Distribution Channel: Retail Sales, Direct Tender
4) By End Users: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users Subsegments,
1) By Diagnosis: Genetic Testing (Genetic Screening), Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)), Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging
2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy (Gene Editing, Retinal Drugs), Photoreceptor Rescue Therapy For further insights on the Inherited Retinal Disease market,
request a sample here

Which region has the largest share of the Inherited Retinal Disease market? What are the other regions covered in the report?

North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Inherited Retinal Disease market, request a sample here.

Who are the major players in the Inherited Retinal Disease market?

Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics . For further insights on the Inherited Retinal Disease market, request a sample here.

What are the key trends in the Inherited Retinal Disease market?

Major trends in the Inherited Retinal Disease market include Innovation In Mutation-Agnostic Gene Therapy Shaping The Market. For further insights on the Inherited Retinal Disease market, request a sample here.

What are the major opportunities in the Inherited Retinal Disease market? What are the strategies for the Inherited Retinal Disease market?

For detailed insights on the major opportunities and strategies in the Inherited Retinal Disease market, request a sample here.

How does the Inherited Retinal Disease market relate to the overall economy and other similar markets?

For detailed insights on Inherited Retinal Disease's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Inherited Retinal Disease industry?

For detailed insights on the mergers and acquisitions in the Inherited Retinal Disease industry, request a sample here.

What are the key dynamics influencing the Inherited Retinal Disease market growth? SWOT analysis of the Inherited Retinal Disease market.

For detailed insights on the key dynamics influencing the Inherited Retinal Disease market growth and SWOT analysis of the Inherited Retinal Disease industry, request a sample here.